MetaCap

CVRx (CVRX) vs QT Imaging (QTI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

CVRx (CVRX) has outperformed QT Imaging (QTI) over the past year, losing 81.6% versus a loss of 91.8%. CVRx is the larger company by market cap ($42.1 million vs $39.2 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CVRX-81.56%QTI-91.79%
+24%-37%-98%
Oct 8, 20251 yearOct 8, 2026
CVRX-90.97%QTI-98.25%
+77%-15%-107%
Nov 1, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CVRX versus QTI key metrics
MetricCVRXQTI
Share price$1.58$2.68
Market cap$42.09M$39.23M
1-day change-5.95%+3.08%
YTD return-76.34%-57.38%
1-year return-81.56%-91.79%
5-year return-89.27%—
EPS (TTM)$-1.97$-1.40
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$11.30$36.75
52-week low$1.50$2.42
Distance from 52-week high-86.02%-92.71%
Analyst consensusnonestrong_buy
Avg. price target upside+189.87%+288.06%
Average volume922.12K34.21K
Shares outstanding26.64M14.64M
Employees22331
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsBiotechnology: Electromedical & Electrotherapeutic Apparatus

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CVRX has outperformed QTI by 10.2 percentage points over the past year.

About CVRx

CVRX stock →

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system.

Health Care · Medical/Dental Instruments · 223 employees

About QT Imaging

QTI stock →

QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems with low frequency sound waves for detection, diagnosis, and treatment of diseases in the United States and Internationally.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 31 employees

CVRX vs QTI FAQ

Which is bigger, CVRx or QT Imaging?

CVRx (CVRX) is larger, with a market capitalization of $42.09M compared with $39.23M for QT Imaging (QTI).

Which stock has performed better over the past year, CVRX or QTI?

CVRX returned -81.56% over the past 12 months, compared with -91.79% for QTI (price return, excluding dividends). Past performance does not predict future results.

Are CVRx and QT Imaging in the same industry?

Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for CVRx and Biotechnology: Electromedical & Electrotherapeutic Apparatus for QT Imaging.

More comparisons